U.S. Securities and Exchange Commission v. Cell>Point, LLC

District Court, D. Colorado·Decided March 15, 2024·No. 1:21-cv-01574·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Chief Judge Philip A. Brimmer

Civil Action No. 21-cv-01574-PAB-SBP

UNITED STATES SECURITIES AND EXCHANGE COMMISSION,

Plaintiff,

v.

CELL>POINT, LLC, GREG COLIP, TERRY COLIP, CELL THERANOSTICS, LTD., and CELL THERANOSTICS, INC.,1

Defendants.

ORDER

The matters before the Court are Plaintiff’s Third Emergency Motion for an Order to Show Cause Why Defendants Should Not be Held in Civil Contempt and Motion for Reconsideration for an Asset Freeze [Docket No. 205], JBA Enterprise, LLC’s Motion to Intervene and Objection to SEC’s Motion for an Asset Freeze [Docket No. 219], and Defendant’s Submission of Request by Advanced Chelation Technologies, Inc. for Consideration of Proposed Transaction Plan [Docket No. 269]. Plaintiff United States Securities and Exchange Commission (the “SEC”) seeks an order holding defendants in contempt and sanctioning defendants for violations of the Court’s Order from December

1 Throughout the period relevant to this litigation, defendants Cell Theranostics, LTD. and Cell Theranostics, Inc. were wholly-owned subsidiaries of Cell>Point, LLC. Docket No. 152 at 5–6, ¶¶ 17, 18. 28, 2022. Docket No. 205 at 1. Specifically, the SEC seeks an order freezing defendants’ assets or requiring that defendants obtain permission from the Court in advance of any solicitation or receipt of money from investors or prospective investors. Id. at 15. In response to the SEC’s motion, the Court ordered defendants to show

cause on why they should not be held in civil contempt. Docket No. 206 at 2. On May 16, 2023, JBA Enterprise, LLC (“JBA”) filed a motion to intervene in this case to oppose the SEC’s motion for an asset freeze as it relates to them and their state court judgment against the defendants. Docket No. 219. Defendants filed a request for the Court to reconsider its imposition of civil sanctions against the defendants and to approve a proposed business transaction on November 11, 2023. Docket No. 269. The SEC filed a response to defendants’ request, Docket No. 275, and defendants filed a reply. Docket No. 278. On December 29, 2023, Advanced Chelation Technologies, Inc. (“Chelation Technologies”) filed a motion to intervene on behalf of previous investors in Cell>Point to oppose the SEC’s motion to reconsider an asset freeze and to support

defendants request to lift the Court’s civil sanctions against defendants. Docket No. 280. I. BACKGROUND The procedural background of this case has been stated at Docket Nos. 93, 138, and 195. It will only be repeated here to the extent necessary to resolve the present motion. On June 10, 2021, the SEC filed this lawsuit against defendants Cell>Point, LLC (“Cell>Point”), Greg Colip, and Terry Colip (collectively “defendants”), bringing claims against all defendants for fraud under Sections 10(b) and 20(a) of the “Exchange Act,” 2 15 U.S.C. § 78j(b), against the individual defendants for aiding and abetting violations of the Exchange Act, against all defendants for fraud in the offer or sale of securities under Section 17(a) of the “Securities Act,” 15 U.S.C. § 77q(a), and against the individual defendants for aiding and abetting violations of the Securities Act.2 Docket No. 1 at 38–

42, ¶¶ 156–70. Defendant Greg Colip is the chief executive officer and a managing member of Cell>Point. Docket No. 93 at 2–3. Defendant Terry Colip is the chief financial officer, as well as a managing member of Cell>Point. Id. at 2. On February 14, 2022, the Court entered a preliminary injunction enjoining defendants from violating securities laws. Id. at 19–22. On July 13, 2022, the Court issued an order (“First Contempt Order”) holding Greg Colip and Terry Colip in civil contempt of the Court’s order dated February 14, 2022. Docket No. 138 at 20. As a remedial sanction, the Court ordered Terry Colip, Greg Colip, and Cell>Point to return $100,000 that they obtained from an investor in violation of the Court’s order enjoining violations of securities law. Id. at 19. The Court further ordered that defendants inform

anyone they asked for a loan in the future with copies of the Court’s preliminary injunction order and of the order holding them in contempt. Id. at 21. The Court ordered defendants contempt purged on October 27, 2022. Docket No. 166. On December 28, 2022, the Court issued an order (“Second Contempt Order”) holding defendants in contempt of the Court’s First Contempt Order. Docket No. 195 at 21. The Court ordered the following:

2 On July 18, 2022, the SEC filed an amended complaint naming Cell Theranostics, Inc. and Cell Theranostics, Ltd., subsidiaries of Cell>Point, as defendants. See Docket No. 140. 3 Within ninety days of this order, defendants Terry Colip, Greg Colip, and Cell>Point shall pay into the Court registry the amounts they received in violation of the Court’s orders from February 14, 2022 and July 13, 2022 in investments in Cell>Point from Corey Helm ($3,137), Eric Verploeg ($8,469), Jeff Johnson ($12,500), and Paul Elliott ($100,000), for a total of $124,106, and shall pay 10% annual interest running from the date of this order. Given that the Court finds Greg and Terry Colip to be in contempt of the above-mentioned orders, they will be jointly and severally responsible for the compensatory sanction along with Cell>Point.

If defendants claim that they do not have the financial ability to pay the sanction when due, they must each provide an explanation for why he or Cell>Point cannot pay with supporting documentation from bank and financial records of Terry Colip, Greg Colip, and Cell>Point.

Additionally, as a coercive measure to ensure defendants obtain any funds necessary to pay the sanction without violating the Court’s February 14, 2022 order, or this order, defendants shall provide paper copies or attach pdf copies of this order and the February 14 and July 13, 2022 orders of the Court (a) to any person who defendants ask to provide a capital call, loan, donation, or investment to Terry Colip, Greg Colip, Cell>Point, Cell Theranostics, Inc., or Cell Theranostics, Ltd. or (b) to any person defendants reasonably believe intends, is considering, or has been solicited by any defendant to provide a capital call, loan, donation, or investment to Terry Colip, Greg Colip, Cell>Point, Cell Theranostics, Inc., or Cell Theranostics, Ltd. When defendants provide copies of the Court’s orders, defendants shall also include the following text in a conspicuous manner in the communication containing the copies: The Court in SEC v. Cell>Point, LLC, et al., 21-cv-01574-PAB-KLM (D. Colo.), has ordered that the attached documents be supplied to any person who is considering an investment or providing money to Cell>Point, LLC, Cell Theranostics, Inc., or Cell Theranostics, Ltd.

The requirement that Terry Colip, Greg Colip, and Cell>Point provide copies of the Court’s orders and the disclosure notice above applies to all solicitations, made by any means, regardless of whether an investor or potential investor has previously been informed of this litigation. Defendants shall continue to provide copies to such investors, or would be investors, in this manner until the Court finds the defendants’ contempt has been purged by paying the sanction. Id. at 17–19. Defendants did not make any payments towards their sanction by April 3, 2023, 4 the date the Court specified as the deadline to pay the sanction. See id. at 21.

Free access — add to your briefcase to read the full text and ask questions with AI

U.S. Securities and Exchange Commission v. Cell>Point, LLC, (D. Colo. 2024).

U.S. Securities and Exchange Commission v. Cell>Point, LLC (U.S. Securities and Exchange Commission v. Cell>Point, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related